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ABSTRACT 
Objective:  To determine outcome of surgical management of Chronic Subdural Hematoma. 
Study Design:  Descriptive Study. 
Materials and Methods:  Patients with Chronic Subdural Hematoma diagnosed on CT scan brain admitted to the 
Neurosurgery Department, Bolan Medical College/Hospital, Quetta Pakistan from January 2008 to December 
2017. Patients included in the study were those who presented with CSDH only and all those patients were 
excluded who had undergone surgery previously elsewhere. At the time of admission the neurological status was 
classified according to a  Grading Scheme  which was proposed by Markwalder et al. Radiological evaluation 
was done by CT Scan before surgery and routine CT Scan of each patient was done one day after surgical inter-
vention, one week after and anytime if required. Outcome was determined by GCS and GOS. Good Recovery and 
Moderate Disability were considered as favorable outcome while Severe Disability, Persistent Vegetative State 
and Death as unfavourable outcome. 
Data Analysis:  SPSS software was used for data analysis. 
Results:  A total of 145 patients were treated with surgical evacuation of CSDH. 121 (83%) patients were men 
while 24 (17%) were women with Male to Female ratio of 5:1.10 (7%) patients had Markwalders Grade 1, 57 
(39%) had Markwalders Grade 2 while 46 (32%) patients had Grade 3 and 32 (22%) had Grade 4. Recurrence 
occurred in 20 (14%) patients. 129 (89%) patients had favourable outcome while 16 (11%) had unfavourable 
outcome. 
Conclusion:  The favourable outcome of surgical evacuation of Chronic Subdural Hematoma is quite high if 
operated early. Moreover, the course and outcome is affected by several factors particularly the initial 
neurological status at the time of diagnosis. 
Key Words:  Chronic Subdural Hematoma, Markwalders Grading, Recurrence, Glasgow Outcome Scale. 
 
INTRODUCTION 
Chronic Subdural Hematoma is the accumulation of 
blood in between the coverings of the brain between 
arachnoid and dura matter in subdural space. It is the 
common neurosurgical entity that clinicians seen in 
routine neurosurgical practice. CSDH commonly 
occurs in the old peoples, may be several weeks after 
traumatic brain injury.
1
 A rise in life expectancy in 
developing countries resulted in an increase in the 
incidence of that condition.
2-5
 Its incidence is very 
high in the 7
th
 and 8
th
 decade of life is; however no age 
is exempt. In earlier decades the incidence rate of 
1.72/100000 per year was estimated, but due to increa-
sing age of 70 – 79 years the incidence rate became 
increased up to 7.35/100000 per year.
6
 The clinical 
presentations of CSDH are variable. They could vary 
from no symptoms to headache, seizures, decline in 
memory and confusion. Patients could have difficulty 
in speech and walking. There may be weakness or 
numbness of any part of body such as arms, legs, and 
face as well as swallowing difficulties.
7
 
 Surgical evacuation is the best treatment in most
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of patients having CSDH. However some of these 
patients could be treated without surgery, especially 
when small hematomas develop after antiplatelet drug 
use. There are many observations of the normal mean 
pressure in subdural space in CSDH.
8 The indications 
for surgery are: patients who are symptomatic with 
neurological deficit and having GCS between 5 – 15, 
midline brain shift more than 0.5cm, thickness of 
hematoma more than 1.5cm and haematoma volume 
more than 25 ml. The main procedure remains the eva-
cuation through burr hole (evacuation by one burr hole 
or by two burr holes, or by craniostomy) along with 
deep sedation by using infiltration of local anestheatic 
agent, and some time with General anesthesia. Thoro-
ugh and meticulous irrigation of subdural space with 
normal saline is done and continued until returning 
normal saline become clear. After irrigation, a closed 
drainage tube and bag placed in subdural space. The 
method of evacuation of haematoma when done with 
local infiltration and sedation minimizes the risks of 
general anesthesia and surgery, and it can be perfor-
med when other co-morbid illnesses are present.
9,10
 
The aim of our study was to evaluate the outcome of 
management of chronic subdural hematoma by surgery 
as determined by Glasgow Outcome Scale so that we 
can share our experience with other health care pro-
fessionals. 
 
MATERIALS AND METHODS 
All consecutive patients who admitted with chronic 
subdural hematoma diagnosed on the basis of CT scan 
brain in the Department of Neurosurgery, Sandeman 
Provincial Teaching Hospital and Bolan Medical 
Complex Hospital, Quetta, Pakistan from January 
2008 to December 2017. We included the patient in 
this study if signs and symptoms were only due to 
CSDH. Patients who were operated previously any-
where else for CSDH and presents with recollection 
were not included in our study. 
 The basic demographic information were recorded 
like name, age, sex, address and hospital registration 
number. At the time of admission clinical status was 
classified and recorded according to a grading system 
for this neurological disorder. This grading system 
ranges from 0 to 4 which was proposed by Mark-
walder et al.
11,12
 Radiological evaluation of CSDH 
including thickness of hematoma, hematoma density, 
midline shift and hematoma volume were calculated 
on the basis of CT scans obtained before doing sur-
gery. Routine laboratory investigations done before the 
surgical procedure. Investigations  included  complete 
blood count with differential, complete profile for co-
agulation disorder including international normalized 
ratio (INR), prothrombin time (PT), activated partial 
thromboplastin time (APTT), platelets count and other 
biochemical investigations. If patient was taking any 
antiplatelet and anticoagulant treatment it was stopped 
on temporary basis before surgery and restarted one 
month after the surgery. If coagulation profile was 
abnormal then we corrected it by administration of 
plasma (FFPs), platelets or Vitamin K where needed 
before surgery. 
 Patients who were symptomatic with neurological 
deficit and with GCS between 5-15, midline brain shift 
more than 0.5cm, thickness of hematoma more than 
1.5cm and volume of hematoma more than 25ml on 
CT scan (Fig-1) underwent surgical procedures. 145 
consecutive patients with CSDH were managed by 
surgical therapy. One burr hole or two burr holes cra-
niostomies were performed, evacuation of hematomas 
done and irrigation of subdural cavity with  meticulous 
amount normal saline through one or two burr holes; 
membranectomy was done where necessary and possi-
ble. Closed drainage system was placed in subdural 
space and remained there for 1 – 2 days after the ope-
ration. Antibiotic were given to all patients prophylac-
tically to prevent infection during the perioperative 
period. After surgery, patients were kept supine with-
out head elevation or pillow for 48 hours to increase 
and facilitate gravitational drainage of remaining fluid 
in the cavity. To promote expansion of the brain pati-
ents were well hydrated given 2L of IV fluids each day 
for about 4 to 5 days, and patients were mobilized as 
early as possible. CT scan brain was done routinely 
after one day of surgery then after ten days and any 
time if required. Measurement of hematoma thickness 
before surgery and ten days after surgery was done by 
CT scan. CT scan also shows the expansion of the 
brain. Patients without any complication were dischar-
ged from the hospital on the 10th postoperative day 
and called for follow up after 6 to 12 weeks. Neurolo-
gical and radiological assessments were done by GCS, 
GOS and CT scan.  We consider Good Recovery and 
Moderate Disability in GOS as favorable outcomes 
and other components of GOS like Severe Disability, 
Persistent Vegetative State and Death, we considered 
them as unfavorable. 
 
Data Analysis 
SPSS software was used. Frequencies of Variables like
Title 
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age, GCS Markwalder‟s clinical grade, CT density of 
hematoma, hematoma thickness, midline shift, brain 
atrophy, antiplatelet and anticoagulation use, seizures, 
recurrences, Good Recovery and Moderate Disability 
in terms of favorable whereas Severe Disability, Per-
sistent Vegetative State and Death in terms of unfavor-
able outcome were described. Male to female ratio 
(M:F) was calculated. 
 
RESULTS 
A total of 145 patients were managed by surgical 
evacuation. There were 121 (83%) men and 24 (17%) 
 
 
 
Fig. 1: Right Frontoparietal Chronic Subdural Hematoma 
with component of acute hematoma. 
 
women. Ratio between Male to Female ratio was 5:1 
(Fig-3). Age ranged from 32 to 85 years and the mean 
age was of 72 years. Markwalder „s Grade 1 patients 
were 10 (7%), Grade 2 were 57 (39%),Grade 3 were 
46 (32%) and Grade 4 were 32 (22%). On CT scan 
isodense hematomas were in 55 (38%) (Fig-2), hypo-
dense were in 39 (27%) hyperdense were in 28 (19%) 
and mixed were in 23 (16%) cases. 23(16%) patients 
had midline shift less than 0.5cm, 74 (51%) had mid-
line shift more than 0.5cm while 48 (33%) having 
midline shift more than 1cm. 106 (73%) patients had 
brain atrophy. Out of total of 145 patients 22 (15%) 
were on antiplatelet and Anticoagulant therapy. 16 
(11%) patients had seizures. Recurrence was observed 
in 20 (14%) patients (Table 1). 129 (89%) patients 
with favorable outcome and 16 (11%) have unfavor-
able outcome (Table 2). 
 
 
 
Fig. 2:  Left Frontoparietal Chronic Subdural Hematoma. 
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24, 17%
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Fig. 3: 
Gender 
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Table 1: 
 
 
No. of Patients 
N = 289 
Percentage 
Markwalder Grade 
Grade 0     0   0% 
Grade 1   10   7% 
Grade 2   57 39% 
Grade 3   46 32% 
Grade 4   32 22% 
CT Scan Density of Hematoma 
Hypodense 
 
27% 
Isodense   55 38% 
Hyperdense   28 19% 
Mixed   23 16% 
Midline shift 
Less the0. 5cm   23 16% 
More the 0.5cm   74 51% 
More the 1cm   48 33% 
Brain atrophy   
Yes 106 73% 
No   39 27% 
Anti-platelet and AC Therapy 
Yes   22 15% 
No 123 85% 
Seizures   
Yes   16 11% 
No 129 89% 
Recurrence 
Yes    20 14% 
No 125 86% 
 
Table 2:  Outcome. 
 
Outcome   
Favorable 129 89% 
Unfavorable   16 11% 
 
DISCUSSION 
Chronic subdural hematoma (CSDH) is thought to be a 
complex collection on the surface of brain between 
arachnoid and dura coverings of the brain and is 
composed of blood, blood degradation products and 
fluid. The first report of CSDH was that of Johannes 
Wepfer in 1657 which is considered as authentic as 
described by D'Errico and German. A patient who died 
as a result of an “apoplectic event, he found a large 
cyst which is filled with blood under  the dura”.13 
Virchow in 1857 hypothesized that inflammation plays 
a major role in the formation of a CSDH and the 
condition was earlier referred as “pachy meningitis 
haemorrhagica interna”.14 In 1914, Trotter emphasized 
the traumatic etiology.
15
 Till the end of  20th century, 
there were controversies on the origin and natural his-
tory of this lesion.
16
 Some authors recognized that tra-
uma and inflammation may both  be the factors that 
may co-exist in the development of CSDH and some-
times very trivial traumatic insult may lead to CSDH.
17
 
 Surgery is the best treatment when indicated but 
the type and extent of surgery is still debatable.
18
 
 The age range in our study was between 32 years 
to 85 years with mean of age 62 years. This differs 
with Ernestus et al and Rovlias et al.
18,19
 In our study 
ratio between male and female was 121:24 (5:1) and it 
nearly correlates a study of Sanbasivan where ratio 
between male and female ratio was 6:1.
20
 
 In our study majority of the patient fall in Mark-
walder Grade 2 (57 patients) followed by Grade 3 (46 
patients), Grade 4 (32 patients) and Grade 1 (10 pati-
ents). Preoperative CT scan shows mostly isodense 
hematoma in 55 patients, hypodense in 39 patients, 
hyperdense in 28 patients, and mixed in 23 in relation 
to the brain parenchyma density. This correlates to a 
study by Rovalis et al.
18
 The CSDH density shows the 
proportion of amount of fresh blood clots in the cavity 
of hematoma and a high proportion means the active 
an high growth of blood vessels into the membrane of 
the CSDH. It may associated with higher rate of CS-
DH recurrence.
21-23 However our study shows no rela-
tion of hematoma recurrence with hematoma density 
which is similar with study by Ohba et al.
24
 
 74 patients of CSDH had midline shift on CT scan 
of more than 0.5cm, 48 patients of CSDH had midline 
shift more than 1cm while 23 patients of CSDH had 
midline shift less than 0.5cm. In our study patients 
having midline shift of more than 10mm have incre-
ased recurrence and poor outcome that correlates with 
most of the studies conducted intenationally.
25
 In our 
Title 
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study 106 patients have brain atrophy and is one of the 
cause of developing CSDH and most of recurrences.
26
 
Previous studies correlates  the rate of recurrence and 
the unfavorable outcome of CSDH with patients hav-
ing more hematoma thickness and increased atrophy of 
brain, and this is in agreement with our series.
27-33
 
 In our series 22 patients out of 145 were on anti-
platelet and Anticoagulant therapy and out of these 22 
patients 10 have recurrences and 4 had poor outcome. 
In this regard findings of our series is consistent with 
previous studies.
34-38
 
 16 patients were having seizures on admission and 
were given antiepileptic drugs before and after sur-
gery. These seizures are not significantly associated 
with recurrence and poor outcome in our series. 
 Recurrence is not uncommon after drainage. It 
ranges from 5 to 18%.
39,40
 In our series it was observed 
in 20 patients (14%). 
 In our study 129 (89%) patients had favorable 
outcome while 16 (11%) patients had unfavorable 
outcome which is close to findings of international 
studies.
40
 
 
CONCLUSION 
CSDH is the commonest neurosurgical entity. The 
overall outcome of surgical treatment is far high in 
patients with good preoperative neurological status. 
Less midline shift, and less brain atrophy Moreover, 
outcome in patients having CSDH are affected and 
modified by several other factors. 
 
Disclosure 
The authors have no financial conflicts of interest. 
 
Address for Correspondence: 
Dr. Irfan Adil 
Department of Neurosurgery, Bolan Medical College 
at Sandeman Provincial Teaching Hospital 
Quetta 87300 Pakistan 
E-mail: doctorirfan777@yahoo.com 
 
REFERENCES 
1. Santarius T, Hutcûnson PJ. Chronic subdural haema-
toma: time to rationalize treatment? Br J Neurosurg. 
2004; 18: 328-32. 
2. Gorelick PB, Weisman SM. Risk of hemorrhagic stroke 
with aspirin use: An update. Stroke, 2005; 36: 1801–7. 
3. Mori K, Maeda M. Surgical treatment of chronic sub-
dural hematoma in 500 consecutive cases: Clinical cha-
racteristics, surgical outcome, complications, and recur-
rence rate. Neurol Med Chir (Tokyo), 2001; 41: 371–
81. 
4. Spallone A, Giuffrè R, Gagliardi FM, Vagnozzi R. Chr-
onic subdural hematoma in extremely aged patients. 
Eur Neurol. 1989; 29: 18–22. 
5. Zingale A, Albanese V, Romano A, Distefano G, Chia-
ramonte J. Traumatic chronic subdural hematoma over 
80 years. A preliminary prospective study. J Neurosurg 
Sci. 1997; 41: 169–73. 
6. Fogelholm R, Heiskanen O, Waltimo O. Chronic sub-
dural hematoma in adults. Inûuence of patient‟s age on 
symptoms, signs, and thickness of hematoma. J Neuro-
surg. 1975; 42: 43-6. 
7. Yad R. Yadav, Vijay Parihar, Hemant Namdev, and 
Jitin Bajaj.Chronic subdural hematoma Asian J Neuro-
surg. 2016 Oct-Dec; 11 (4): 330–342. 
8. Sundstrøm T, Helland CA, Aarhus M, Wester K. What 
is the pressure in chronic subdural hematomas? A pros-
pective, population-based study. J Neurotrauma. 2012; 
29: 137–42. 
9. Suzuki K, Sugita K, Akai T, Takahata T, Sonobe M, 
Takahasû S. Treatment of chronic subdural hematoma 
by closed-system drainage without irrigation. Surg 
Neurol. 1998; 50: 231-4. 
10. Sambasivan M. An overview of chronic subdural 
hematoma: experience with 2300 cases. Surg Neurol. 
1997; 47: 418-22. 
11. Markwalder TM, Seiler RW. Chronic subdural hema-
tomas: To drain or not to drain? Neurosurgery, 1985; 
16: 185–8. 
12. Markwalder TM, Steinsiepe KF, Rohner M, Reichen-
bach W, Markwalder H. The course of chronic subdural 
hematomas after burr-hole craniostomy and closed-sys-
tem drainage. J Neurosurg. 1981; 55: 390–6. 
13. D'Errico AP, German WJ. Chronic Subdural Hema-
toma. Yale J Biol Med. 1930; 3: 11–20. 
14. Virchow R. Haematoma Durae Matris. Verhandl Phys-
med Gesellsch Wurzburg. 1857; 7: 134–42. 
15. Trotter W. Chronic subdural hæmorrhage of traumatic 
origin, and its relation to pachymeningitishæmorrha-
gicainterna. Br J Surg. 1914; 2: 271–291. 
16. Liau LM, Bergsneider M, Becker DP. Pathology and 
pathophysiology of head injury. In: Youmans JR, edi-
tor. Neurological surgery. ed 4. Vol 3. Philadelphia: 
Saunders; 1996: pp. 1549–1594. 
17. Putnam TJ, Cushing H. Chronic subdural hematoma: its 
pathology, its relation to pachymeningitishemorrhagica, 
and its surgical treatment. Arch Surg. 1925; 11 (3): 
329–3. Doi: 10.1001/archsurg.1925.01120150002001. 
18. Ernestus RI, Beldzinski P, Lanfermann‟ H, KIug N. 
Chronic subdural hematoma: Surgical treatment and 
outcorne in 104 patients. Surg Neurol. 1997; 48: 220-5. 
19. Aristedis Rovlias, Spyridon The odoropoulos, Dimit-
rios Papoutsakis. Chronic subdural hematoma: Surgical 
management and outcome in 986 cases: A classification 
Author, et al 
-66-         Pak. J. of Neurol. Surg. – Vol. 22, No. 2, Apr. – Jun., 2018 
and regression tree approach. Surg Neurol Int. 2015; 6: 
127. 
20. Sambasivan M. An overview of chronic subdural hema-
toma: experience with 2300 cases. Surg Neurol. 1997; 
47: 418-22. 
21. Ko BS, Lee JK, Seo BR, Moon SJ, Kim JH, Kim SH. 
Clinical analysis of risk factors related to recurrent 
chronic subdural hematoma. J Korean Neurosurg Soc. 
2008; 43: 11–1. 
22. Oishi M, Toyama M, Tamatani S, Kitazawa T, Saito M. 
Clinical factors of recurrent chronic subdural hema-
toma. Neurol Med Chir (Tokyo), 2001; 41: 382–386. 
23. Ahn SY, Kim JH, Ha SK, Kim JH, Kwon TH, Park 
YK, et al. Clinical analysis of risk factors associated 
with the recurrence of chronic subdural hematoma. J 
Korean Neurotraumatol Soc. 2011; 7: 68–73. 
24. Ohba S, Kinoshita Y, Nakagawa T, Murakami H. The 
risk factors for recurrence of chronic subdural hema-
toma. Neurosurg Rev. 2013; 36: 145–149. Discussion 
149-150. 
25. Mastronardi L, Puzzilli F, Ruggeri A, Guiducci A. 
Magnetic resonance imaging findings of Kernohan-
Woltman notch in acute subdural hematoma. Clin Neu-
rol Neurosurg. 1999 Jun;101 (2): 122-4. 
26. Jeong SI, Kim SO, Won YS, Kwon YJ, Choi CS. Clini-
cal Analysis of Risk Factors for Recurrence in Patients 
with Chronic Subdural Hematoma Undergoing Burr 
Hole Trephination. Korean J Neurotrauma. 2014 Apr; 
10 (1): 15-21. 
27. Amirjamshidi A, Abouzari M, Eftekhar B, Rashidi A, 
Rezaii J, Esfandiari K, Shirani A, Asadollahi M, Ale-
alix H. Outcomes and recurrence rates in chronic sub-
duralhaematoma. Br J Neurosurg. 2007 Jun; 21 (3): 
272-5. 
28. Kaczmarczyk R, Osuchowski J, Trojanowski T, Turo-
wski K, Rakowski P. Early results of surgical treatment 
of chronic subdural hematoma in CT images. Neurol 
Neurochir Pol. 1994; 28: 693–701. 
29. Kim HY, Kwon SC, Kim TH, Shin HS, Hwang YS, 
Park SK. Analysis of management according to CT 
findings in chronic subdural hematoma. J Korean Neu-
rosurg Soc. 2005; 37: 96–100. 
30. Mori K, Maeda M. Surgical treatment of chronic sub-
dural hematoma in 500 consecutive cases: Clinical cha-
racteristics, surgical outcome, complications, and recur-
rence rate. Neurol Med Chir (Tokyo), 2001; 41: 371–
81. 
31. Nakaguchi H, Tanishima T, Yoshimasu N. Factors in 
the natural history of chronic subdural hematomas that 
influence their postoperative recurrence. J Neurosurg. 
2001; 95: 256–62. 
32. Oishi M, Toyama M, Tamatani S, Kitazawa T, Saito M. 
Clinical factors of recurrent chronic subdural hema-
toma. Neurol Med Chir (Tokyo), 2001; 41: 382–6. 
33. Okada Y, Akai T, Okamoto K, Iida T, Takata H, Iizuka 
H. A comparative study of the treatment of chronic sub-
dural hematoma – Burr hole drainage versus burr hole 
irrigation. Surg Neurol. 2002; 57: 405–9. 
34. Chen JC, Levy ML. Causes, epidemiology, and risk 
factors of chronic subdural hematoma. NeurosurgClinN 
Am. 2000; 11: 399–406. 
35. Choi WW, Kim KH. Prognostic factors of chronic sub-
dural hematoma. J Korean Neurosurg Soc. 2004; 35: 
192–8. 
36. De Bonis P, Trevisi G, de Waure C, Sferrazza A, Volpe 
M, Pompucci A, et al. Antiplatelet/anticoagulant agents 
and chronic subdural hematoma in the elderly. PLoS 
One, 2013; 8: e68732. 
37. Delgado PD, Cogolludo FJ, Mateo O, Cancela P, Gar-
cía R, Carrillo R. Early prognosis in chronic subdural 
hematomas. Multivariate analysis of 137 cases. Rev 
Neurol. 2000; 30: 811–7. 
38. Forster MT, Mathé AK, Senft C, Scharrer I, Seifert V, 
Gerlach R. The influence of preoperative anticoagu-
lation on outcome and quality of life after surgical 
treatment of chronic subdural hematoma.J Clin Neuro-
sci. 2010; 17: 975–9. 
39. Tsutsumi K, Maeda K, Iijima A, Usui M, Okada Y, 
Kirino T. The relationship of preoperative magnetic 
resonance imaging findings and closed system drainage 
in the recurrence of chronic subdural hematoma, J Neu-
rosurg. 1997; 87: 870-5. 
40. Das S, Sarkar AC, Islam MR, and Islam MM. Surgical 
Outcome of Chronic Subdural Haematoma: An Ana-
lysis of 300 Cases. J Dhaka Med Coll. 2015; 24 (2): 
126-131. 
 
AUTHORS DATA 
 
Name Post Institution E-mail Role of Authors 
Dr. Naqib Ullah Achakzai  
Department of Neurosurgery, 
Bolan Medical College/ 
Sandeman Provincial 
Teaching Hospital, Quetta 
87300 Pakistan 
achakzai_66@hotmail.com 
Writing of the 
Paper 
Dr. Irfan Adil  doctorirfan777@yahoo.com Data Collection 
Dr. Saleem Khan   Data Analysis 
 
Date of Submission: 15-4-2018 Date of Printing: 30-6-2018 
Peer Reviewed by Dr. Fauzia Sajjad, Amir Aziz and Chief Editor Prof. Dr. Muhammad Anwar Chaudary and 
others. 
